Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Amgen's FOLR1-BiTE antibody constructs target folate receptor 1 in ovarian tumors

May 25, 2016

ZVex/mIL12 shows promising antitumor effect in vivo

May 24, 2016

Darzalex receives European conditional marketing authorization for multiple myeloma

May 24, 2016

Cyramza receives additional indication approval for colorectal cancer in Japan

May 23, 2016

Xencor generates bispecific antibodies targeting prostate-specific membrane antigen and CD3

May 23, 2016

Halozyme anti-EGFR ADC is active against tumors with resistance mutations

May 23, 2016

Response, safety data updated for cancer vaccine INO-3112 in HPV-associated HNSCC trial

May 23, 2016

Regen Biopharma starts preclinical development of universal donor immunotherapy

May 23, 2016

Eureka Therapeutics CAR-T therapy targeting antigen/MHC complexes to enter phase I

May 20, 2016

Pelican Therapeutics wins NCPD award for the development of TNFRSF25 agonists

May 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...